Psorcon Recall

Get an alert when a recall is issued.

Questions & Answers

Side Effects & Adverse Reactions

There is currently no warning information available for this product. We apologize for any inconvenience.

Legal Issues

There is currently no legal information available for this drug.

FDA Safety Alerts

There are currently no FDA safety alerts available for this drug.

Manufacturer Warnings

There is currently no manufacturer warning information available for this drug.

FDA Labeling Changes

There are currently no FDA labeling changes available for this drug.


psorcon (diflorasone diacetate cream), 0.05% is a high potency corticosteroid indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.


There is currently no drug history available for this drug.

Other Information

psorcon® (diflorasone diacetate cream) contains the active compound diflorasone diacetate, a synthetic corticosteroid for topical dermatological use.

Chemically, diflorasone diacetate is 6α,9α-difluoro-11β,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione 17,21 diacetate, with the empirical formula C26H32F2O7, a molecular weight of 494.5, and the following structural formula:

Image from Drug Label Content

Each gram of psorcon Cream contains 0.5 mg diflorasone diacetate in a cream base consisting of purified water USP, propylene glycol USP, mineral oil (and) lanolin alcohol, glyceryl stearate SE (nonionic), isopropyl myristate NF, polysorbate 60 NF, sorbitan monostearate NF, polyoxyl 40 stearate NF, cetyl alcohol NF, monobasic sodium phosphate USP, vegetable oil, monoglyceride citrate, BHT and citric acid.

Psorcon Manufacturers

  • Dermik Laboratories, Inc.
    Psorcon (Diflorasone Diacetate) Cream [Dermik Laboratories, Inc.]
  • Taro Pharmaceuticals U.s.a., Inc.
    Psorcon (Diflorasone Diacetate) Cream [Taro Pharmaceuticals U.s.a., Inc.]

Login To Your Free Account